VAERS reports by lot

GSK Varicella/Shingles lot ZM3D2: VAERS reports

20 VAERS reports list lot ZM3D2 as a GSK Varicella/Shingles vaccine, received between 2020-02-20 and 2021-09-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1124%
Musculoskeletal715%
Dermatological (non-injection-site)715%
Allergic / Anaphylactic613%
General / Systemic (non-local)613%
Neurological37%
Thrombotic / Hematological24%
Cardiac / Cardiovascular12%
Gastrointestinal12%
Psychiatric / Neuropsychiatric12%
Reproductive / Menstrual12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania6
Maine2
Indiana1
Texas1
Florida1
Colorado1
New Hampshire1
Connecticut1
New Jersey1
Ohio1
Washington1
North Carolina1

Reports by month received

2020-022
2020-052
2020-063
2020-072
2020-081
2020-093
2020-102
2021-022
2021-072
2021-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.